[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2002308159A1 - 3,5-diamino-1,2,4-triazoles as kinase inhibitors - Google Patents

3,5-diamino-1,2,4-triazoles as kinase inhibitors

Info

Publication number
AU2002308159A1
AU2002308159A1 AU2002308159A AU2002308159A AU2002308159A1 AU 2002308159 A1 AU2002308159 A1 AU 2002308159A1 AU 2002308159 A AU2002308159 A AU 2002308159A AU 2002308159 A AU2002308159 A AU 2002308159A AU 2002308159 A1 AU2002308159 A1 AU 2002308159A1
Authority
AU
Australia
Prior art keywords
triazoles
diamino
kinase inhibitors
kinase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002308159A
Inventor
Martin Kruger
Orlin Petrov
Gerhard Siemeister
Karl-Heinz Thierauch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU2002308159A1 publication Critical patent/AU2002308159A1/en
Abandoned legal-status Critical Current

Links

AU2002308159A 2001-05-08 2002-04-24 3,5-diamino-1,2,4-triazoles as kinase inhibitors Abandoned AU2002308159A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10123586.0 2001-05-08

Publications (1)

Publication Number Publication Date
AU2002308159A1 true AU2002308159A1 (en) 2002-12-03

Family

ID=

Similar Documents

Publication Publication Date Title
AU2001237041A1 (en) Kinase inhibitors
MXPA03002297A (en) Triazole compounds useful as protein kinase inhibitors.
ZA200206386B (en) Kinase inhibitors.
HUP0202713A3 (en) Pteridinones as kinase inhibitors
AU2002362895A1 (en) 5-carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
MXPA03008690A (en) Novel tyrosine kinase inhibitors.
AU2002305260A1 (en) Pyrazole derived kinase inhibitors
AU2002346929A1 (en) 5-acylamino-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
AU2002361577A1 (en) Tyrosine kinase inhibitors
AU2002324462A1 (en) Tmart memory
AU2002348394A1 (en) Tyrosine kinase inhibitors
AU2002348020A1 (en) Tyrosine kinase inhibitors
AU2002348393A1 (en) Tyrosine kinase inhibitors
AU2002323406A1 (en) Tyrosine kinase inhibitors
AU2002210444A1 (en) Quinazolines, medicaments, which contain these compounds and which are effectiveas tyrosine kinase inhibitors, their use, and methods for the production thereo f
AU2002327534A1 (en) Tyrosine kinase inhibitors
AU2002253350A1 (en) 4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors
AU2002308159A1 (en) 3,5-diamino-1,2,4-triazoles as kinase inhibitors
AU2001238193A1 (en) 27802, an adenylate kinase
AU2002310556A1 (en) 2-adamantyl-4,6-diamino-1,2-dihydro-1-aryl-1,3,5-triazine derivatives as cell prolifiration inhibitors
AU2002361027A1 (en) Substituted 1,5-diaminopentan-3-ol compounds
AU2002246255A1 (en) Jun kinase inhibitors
AU2002339506A1 (en) Heterocycle-carboxamide derivatives as raf kinase inhibitors
ZA200301704B (en) Triazole compounds useful as protein kinase inhibitors.
AU2002337972A1 (en) Tyrosine kinase inhibitors